Understanding the Increased Risk of Childhood Acute Lymphoblastic Leukemia in Latinos
了解拉丁裔儿童儿童急性淋巴细胞白血病风险增加
基本信息
- 批准号:10629825
- 负责人:
- 金额:$ 13.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-05-01 至 2027-04-30
- 项目状态:未结题
- 来源:
- 关键词:AccountingAcute Lymphocytic LeukemiaAddressAdministrative SupplementAmericasAwardCaliforniaCesarean sectionCessation of lifeChildChildhoodChildhood Acute Lymphocytic LeukemiaChildhood LeukemiaComplexCountryCytomegalovirus InfectionsDiseaseEnvironmental Risk FactorEpidemiologyEthnic OriginEthnic groupEtiologyEuropeanExhibitsFaceFutureGeneticGenetic Predisposition to DiseaseGenetic RiskGenetic VariationGenomeGenotypeGoalsGroup IdentificationsGuatemalaHispanicHumanImmune responseImmunological ModelsIncidenceInfectionInferiorInvestigationLatin AmericanLatinoLatino PopulationLightMalignant Childhood NeoplasmMalignant NeoplasmsMeta-AnalysisMexicanMexicoMinority GroupsModelingMorbidity - disease rateNative American AncestryNative AmericansNatural SelectionsNatureOutcomeParentsPatient-Focused OutcomesPatientsPediatric Oncology GroupPerformancePlayPopulationPreventionRecording of previous eventsResearchRiskRisk FactorsRoleSaint Jude Children&aposs Research HospitalSample SizeSamplingSurvivorsTexasTimeTreesTumor SubtypeUnited StatesValidationVariantadmixture mappingbasecase controlcausal variantdata repositorydisease disparitydisorder preventiondisorder riskepidemiologic dataethnic disparityethnic minorityexperiencegenetic analysisgenetic associationgenetic resourcegenetic variantgenome wide association studygenome-widehigh riskhigh risk populationimprovedin uteroinsightinterestmodifiable riskmortalitynon-geneticnovelphenotypic datapolygenic risk scorepreventracial and ethnicracial minorityrelapse riskresponserisk stratificationrisk varianttranscriptome
项目摘要
ABSTRACT
This application is being submitted in response to the Notice of Special Interest (NOSI) identified as
NOT-CA-22-056. Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer and, despite
advances in treatment, it is still one of the leading causes of childhood death in the United States (US), and
survivors face significant lifelong treatment-related morbidities. Children of Latino ethnicity have the highest
and fastest-increasing risk of ALL in the US, and have lower survival than non-Latino whites; however, this
ethnic disparity in incidence and outcome is not fully understood. Elucidating the increased risk of ALL in Latino
children may reveal novel insights in the etiology of ALL in both Latino and non-Latino populations, and may
highlight potential avenues for disease prevention. We hypothesize that germline genetic variation plays an
essential role in the increased ALL risk in Latinos, that this risk is imparted via Native American ancestry, and
that ALL risk alleles were selected in Native Americans during European colonization of the Americas due to
their beneficial effects on immune response to new infections. We have assembled the largest ever case-
control set of childhood ALL in Latinos, including over 5,400 cases and 27,000 controls from three independent
studies in California, plus studies in Texas, Children’s Oncology Group/St. Jude Children’s Research Hospital,
and Guatemala. In our first aim, we will perform three complementary approaches to discover novel common
risk loci associated with childhood ALL: i) a genome-wide association study (GWAS) meta-analysis, ii)
admixture mapping to capitalize on the recently admixed nature of Latino genomes, and iii) a transcriptome-
wide association study to identify novel loci and to pinpoint causal genes at known and novel risk regions. In
our second aim, we will characterize the genetic variants in terms of their association with local Native
American ancestry and whether they exhibit evidence of directional natural selection on the Native American
branch of the human population tree. We will also characterize the aggregate effects of common variants on
childhood ALL risk and how this varies by ethnicity, via comprehensive modeling of polygenic risk scores
(PRS) for ALL in Latinos and in non-Latino whites. Finally, we will incorporate our genetic findings into
epidemiologic analyses, by accounting for common (PRS) genetic variants in ALL risk models for immune-
related risk factors in Latinos and non-Latino whites, including cesarean delivery and in utero cytomegalovirus
infection, both of which have shown stronger effects on ALL risk in Latinos and are potentially modifiable risk
factors. The results of this study will shed light on the etiology of childhood ALL in general and of the increased
risk of ALL in Latino children, which will help to alleviate this ethnic disparity and may inform future approaches
for childhood leukemia prevention.
摘要
本申请是为了响应特别利益通知(NOSI)而提交的,该通知被确定为
NOT-CA-22-056。急性淋巴细胞白血病(ALL)是最常见的儿科癌症,
尽管治疗取得了进展,但它仍然是美国儿童死亡的主要原因之一,
幸存者面临着终身治疗相关的疾病。拉丁裔的孩子有最高的
在美国,ALL的风险增加最快,生存率低于非拉丁裔白人;然而,
发病率和结果的种族差异尚未得到充分了解。阐明拉丁美洲人ALL的风险增加
在拉丁裔和非拉丁裔人群中,儿童可能揭示ALL病因的新见解,
突出疾病预防潜在途径。我们假设,生殖系遗传变异发挥了重要作用,
在拉丁美洲人的ALL风险增加中起着至关重要的作用,这种风险是通过美洲原住民血统传递的,
在欧洲殖民美洲期间,美洲原住民选择了ALL风险等位基因,
它们对新感染的免疫反应的有益作用。我们收集了有史以来最大的案件-
拉丁美洲儿童ALL的对照组,包括来自三个独立研究机构的5,400多例病例和27,000例对照。
在加州的研究,加上在得克萨斯州的研究,儿童肿瘤组/圣裘德儿童研究医院,
和危地马拉。在我们的第一个目标,我们将执行三个互补的方法来发现新的共同点,
与儿童ALL相关的风险基因座:i)全基因组关联研究(GWAS)荟萃分析,ii)
混合映射,以利用最近拉丁美洲基因组的混合性质,和iii)转录组-
广泛的关联研究,以确定新的基因座,并查明在已知和新的风险区域的致病基因。在
我们的第二个目标是,我们将根据它们与当地土著人的联系来描述遗传变异。
美国血统,以及他们是否表现出对美洲原住民的定向自然选择的证据
人口树的分支。我们还将描述常见变异体对
通过多基因风险评分的综合建模,了解儿童ALL风险及其随种族的变化
(PRS)所有拉丁裔和非拉丁裔白人。最后,我们将把我们的基因发现纳入
流行病学分析,通过解释免疫相关ALL风险模型中的常见(PRS)遗传变异,
拉丁美洲人和非拉丁美洲白人的相关风险因素,包括剖宫产和子宫内巨细胞病毒
感染,这两种感染都对拉丁美洲人的ALL风险有更强的影响,并且是潜在的可改变的风险
因素这项研究的结果将阐明儿童ALL的一般病因,以及儿童ALL发病率增加的原因。
拉丁裔儿童ALL的风险,这将有助于缓解这种种族差异,并可能为未来的方法提供信息
儿童白血病的预防。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Adam De Smith其他文献
Adam De Smith的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Adam De Smith', 18)}}的其他基金
Understanding the Increased Risk of Childhood Acute Lymphoblastic Leukemia in Latinos
了解拉丁裔儿童儿童急性淋巴细胞白血病风险增加
- 批准号:
10615852 - 财政年份:2022
- 资助金额:
$ 13.22万 - 项目类别:
Understanding the Increased Risk of Childhood Acute Lymphoblastic Leukemia in Latinos
了解拉丁裔儿童儿童急性淋巴细胞白血病风险增加
- 批准号:
10440966 - 财政年份:2022
- 资助金额:
$ 13.22万 - 项目类别:
Genetic determinants of lymphocyte traits and risk of acute lymphoblastic leukemia in children with Down syndrome
唐氏综合症儿童淋巴细胞特征和急性淋巴细胞白血病风险的遗传决定因素
- 批准号:
10700064 - 财政年份:2022
- 资助金额:
$ 13.22万 - 项目类别:
Backtracking Leukemia-Typical Somatic Alterations in Cord Blood at Single-cell Resolution
以单细胞分辨率回溯脐带血中白血病典型体细胞改变
- 批准号:
10459501 - 财政年份:2021
- 资助金额:
$ 13.22万 - 项目类别:
Backtracking Leukemia-Typical Somatic Alterations in Cord Blood at Single-cell Resolution
以单细胞分辨率回溯脐带血中白血病典型体细胞改变
- 批准号:
10693149 - 财政年份:2021
- 资助金额:
$ 13.22万 - 项目类别:
Backtracking Leukemia-Typical Somatic Alterations in Cord Blood at Single-cell Resolution
以单细胞分辨率回溯脐带血中白血病典型体细胞改变
- 批准号:
10274321 - 财政年份:2021
- 资助金额:
$ 13.22万 - 项目类别:
Exploring the shared genetic architecture of white blood cell variation and childhood acute lymphoblastic leukemia
探索白细胞变异和儿童急性淋巴细胞白血病的共同遗传结构
- 批准号:
10063853 - 财政年份:2019
- 资助金额:
$ 13.22万 - 项目类别:
相似海外基金
Understanding of the onset and recurrence pattern of intractable acute lymphocytic leukemia based on clone analysis
基于克隆分析了解难治性急性淋巴细胞白血病的发病和复发模式
- 批准号:
20K08723 - 财政年份:2020
- 资助金额:
$ 13.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Novel Inhibitors of Multi-Drug-Resistant Mutants of BCR-ABL for the Treatment of Chronic Myelogenous Leukemia (CML) and Ph Positive Acute Lymphocytic Leukemia (ALL).
BCR-ABL 多重耐药突变体的新型抑制剂,用于治疗慢性粒细胞白血病 (CML) 和 Ph 阳性急性淋巴细胞白血病 (ALL)。
- 批准号:
9047400 - 财政年份:2015
- 资助金额:
$ 13.22万 - 项目类别:
The Role of Genetic Variants in Sensitivity to Methotrexate in Acute Lymphocytic Leukemia Survivors
遗传变异在急性淋巴细胞白血病幸存者对甲氨蝶呤敏感性中的作用
- 批准号:
319114 - 财政年份:2014
- 资助金额:
$ 13.22万 - 项目类别:
Fellowship Programs
Targeting the Bone Marrow Microenvironment In Acute Lymphocytic Leukemia
针对急性淋巴细胞白血病的骨髓微环境
- 批准号:
8595788 - 财政年份:2013
- 资助金额:
$ 13.22万 - 项目类别:
Targeting hypoxic microenvironment in Acute Lymphocytic Leukemia
针对急性淋巴细胞白血病的缺氧微环境
- 批准号:
8023518 - 财政年份:2011
- 资助金额:
$ 13.22万 - 项目类别:
Targeting hypoxic microenvironment in Acute Lymphocytic Leukemia
针对急性淋巴细胞白血病的缺氧微环境
- 批准号:
8404025 - 财政年份:2011
- 资助金额:
$ 13.22万 - 项目类别:
Targeting hypoxic microenvironment in Acute Lymphocytic Leukemia
针对急性淋巴细胞白血病的缺氧微环境
- 批准号:
8220724 - 财政年份:2011
- 资助金额:
$ 13.22万 - 项目类别:
Targeting hypoxic microenvironment in Acute Lymphocytic Leukemia
针对急性淋巴细胞白血病的缺氧微环境
- 批准号:
8599754 - 财政年份:2011
- 资助金额:
$ 13.22万 - 项目类别:
INSULIN RESISTANCE IN CHILDREN WITH ACUTE LYMPHOCYTIC LEUKEMIA UNDERGOING INDUCT
正在接受治疗的急性淋巴细胞白血病儿童的胰岛素抵抗
- 批准号:
8356701 - 财政年份:2010
- 资助金额:
$ 13.22万 - 项目类别:
INSULIN RESISTANCE IN CHILDREN WITH ACUTE LYMPHOCYTIC LEUKEMIA UNDERGOING INDUCT
正在接受治疗的急性淋巴细胞白血病儿童的胰岛素抵抗
- 批准号:
8166720 - 财政年份:2009
- 资助金额:
$ 13.22万 - 项目类别: